One of Congress's goals in enacting the America Invents Act ("AIA") was to reduce the high cost of litigation involving patents that are invalid. In furtherance of this goal, Congress established inter partes review ("IPR") and covered business method patent review ("CBM review") to provide an alternative to district court litigation. The AIA's text and legislative history reflects an expectation in Congress that, under appropriate circumstances, concurrently pending district court litigation will be stayed while IPR or CBM review is performed by the Patent Trial and Appeal Board (the "Board").
Please click here to read the full text and footnotes of this article
Originally published in Intellectual Property Today's October 2014 issue.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.